Sanguinaria Comp. Pellets 2 D Pellet is a Health Canada–registered human drug (DIN 02232738) held by Wala Heilmittel GmbH, containing Sanguinaria Canadensis. Health Canada lists its status as Cancelled Post Market (status date 03 Aug 2000). Nexara Health has matched 11 registrations of Sanguinaria Canadensis across 2 other regulated markets, 9 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02232738 |
|---|---|
| Brand name | Sanguinaria Comp. Pellets |
| Active ingredient | Sanguinaria Canadensis |
| Strength | 2 D |
| Dosage form | Pellet |
| Route | Oral |
| Company | Wala Heilmittel GmbH |
| Status | Cancelled Post Market — 03 Aug 2000 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Sanguinaria Canadensis registered in other markets
11 registrations of the same molecule in 2 national registries outside Canada (first 9 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United Arab Emirates | Sanguinaria Canadensis - Boiron | BOIRON, France, Messimy | MT to 200 CH | Pillules | Active | EDE |
| United States | Sanguinaria Canadensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sanguinaria Canadensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sanguinaria Canadensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sanguinaria Canadensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sanguinaria Canadensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sanguinaria Canadensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sanguinaria Canadensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sanguinaria Canadensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Sanguinaria Canadensis worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Sanguinaria Comp. Pellets (DIN 02232738) marketed in Canada?
No. Health Canada lists DIN 02232738 as Cancelled Post Market as of 03 Aug 2000.
Who holds the Canadian licence for this product?
Wala Heilmittel GmbH is the company of record in the Health Canada Drug Product Database.
Is Sanguinaria Canadensis registered outside Canada?
Yes — Nexara Health has matched 11 registrations in 2 other markets, including 9 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02232738, status date 2000-08-03; national medicine registries: EDE, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02232738, status date 2000-08-03; national medicine registries: EDE, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02232738, status date 2000-08-03; national medicine registries: EDE, FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.